Skip to main content
. 2021 Jun 21;7(6):e07363. doi: 10.1016/j.heliyon.2021.e07363

Table 5.

Effect of AEPN on α-amylase, α-glucosidase, and lipase enzyme.

Plant extract Percentage inhibition (%)
Pancreatic α-amylase Pancreatic α-glucosidase Pancreatic lipase
AEPN1 29.09 ± 0.21b 10.79 ± 2.61b 10.04 ± 0.27b
AEPN2 34.96 ± 0.35 14.03 ± 0.94b 14.13 ± 0.42b
AEPN3 37.17 ± 0.82 27.89 ± 0.35b 26.11 ± 2.85b
AEPN4 40.04 ± 0.27 37.92 ± 0.88b 33.89 ± 1.26b
AEPN5 42.83 ± 0.51a 48.56 ± 0.64a 54.47 ± 1.91a
Acarbose 54.67 ± 0.45a 87.51 ± 0.27a Not used
Orlistat Not used Not used 83.60 ± 0.20a
Enzyme 0.00 ± 0.00b 0.00 ± 0.00b 0.00 ± 0.00b

n = 3, Data are expressed as mean ± S.E.M. ap≤0.05 is statistical significant difference in comparison with enzyme, bp≤0.05 is statistical significant difference in comparison with acarbose or orlistat. AEPN (1, 2, 3, 4, and 5), Acarbose and orlistat are at concentration of 50, 100, 150, 200, 250, 250 μg/mL and 100 μg/mL respectively.